Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 55

1.

The Immunomodulatory Potential of Mesenchymal Stem Cells in a Retinal Inflammatory Environment.

Hermankova B, Kossl J, Bohacova P, Javorkova E, Hajkova M, Krulova M, Zajicova A, Holan V.

Stem Cell Rev Rep. 2019 Dec;15(6):880-891. doi: 10.1007/s12015-019-09908-0.

PMID:
31863334
2.

The interconnection between cytokeratin and cell membrane-bound β-catenin in Sertoli cells derived from juvenile Xenopus tropicalis testes.

Nguyen TMX, Vegrichtova M, Tlapakova T, Krulova M, Krylov V.

Biol Open. 2019 Dec 20;8(12). pii: bio043950. doi: 10.1242/bio.043950.

3.

Interleukin-10 production by B cells is regulated by cytokines, but independently of GATA-3 or FoxP3 expression.

Bohacova P, Kossl J, Hajkova M, Hermankova B, Javorkova E, Zajicova A, Krulova M, Holan V.

Cell Immunol. 2020 Jan;347:103987. doi: 10.1016/j.cellimm.2019.103987. Epub 2019 Sep 13.

PMID:
31787200
4.

Cytokine interplay among the diseased retina, inflammatory cells and mesenchymal stem cells - a clue to stem cell-based therapy.

Holan V, Hermankova B, Krulova M, Zajicova A.

World J Stem Cells. 2019 Nov 26;11(11):957-967. doi: 10.4252/wjsc.v11.i11.957. Review.

5.

Cyclosporine A promotes the therapeutic effect of mesenchymal stem cells on transplantation reaction.

Hajkova M, Jaburek F, Porubska B, Bohacova P, Holan V, Krulova M.

Clin Sci (Lond). 2019 Nov 15;133(21):2143-2157. doi: 10.1042/CS20190294.

PMID:
31654074
6.

Erratum to "Epithelial-Mesenchymal Transition Promotes the Differentiation Potential of Xenopus tropicalis Immature Sertoli Cells".

Nguyen TMX, Vegrichtova M, Tlapakova T, Krulova M, Krylov V.

Stem Cells Int. 2019 Aug 6;2019:4081950. doi: 10.1155/2019/4081950. eCollection 2019.

7.

Epithelial-Mesenchymal Transition Promotes the Differentiation Potential of Xenopus tropicalis Immature Sertoli Cells.

Nguyen TMX, Vegrichtova M, Tlapakova T, Krulova M, Krylov V.

Stem Cells Int. 2019 May 5;2019:8387478. doi: 10.1155/2019/8387478. eCollection 2019. Erratum in: Stem Cells Int. 2019 Aug 6;2019:4081950.

8.

Kinetics of Helios(+) and Helios(-) T regulatory cell subsets in the circulation of healthy pregnant women.

Kopřivová H, Hájková M, Koucký M, Malíčková K, Holáň V, Krulová M.

Scand J Immunol. 2019 Apr;89(4):e12754. doi: 10.1111/sji.12754. Epub 2019 Mar 4.

PMID:
30729559
9.

Immunomodulatory Properties of Bone Marrow Mesenchymal Stem Cells from Patients with Amyotrophic Lateral Sclerosis and Healthy Donors.

Javorkova E, Matejckova N, Zajicova A, Hermankova B, Hajkova M, Bohacova P, Kossl J, Krulova M, Holan V.

J Neuroimmune Pharmacol. 2019 Jun;14(2):215-225. doi: 10.1007/s11481-018-9812-7. Epub 2018 Sep 21.

PMID:
30242613
10.

The Impact of Morphine on the Characteristics and Function Properties of Human Mesenchymal Stem Cells.

Holan V, Cechova K, Zajicova A, Kossl J, Hermankova B, Bohacova P, Hajkova M, Krulova M, Svoboda P, Javorkova E.

Stem Cell Rev Rep. 2018 Dec;14(6):801-811. doi: 10.1007/s12015-018-9843-8.

PMID:
30136142
11.

The effect of clinically relevant doses of immunosuppressive drugs on human mesenchymal stem cells.

Javorkova E, Vackova J, Hajkova M, Hermankova B, Zajicova A, Holan V, Krulova M.

Biomed Pharmacother. 2018 Jan;97:402-411. doi: 10.1016/j.biopha.2017.10.114. Epub 2017 Nov 6.

PMID:
29091890
12.

Exploitation of stable nanostructures based on the mouse polyomavirus for development of a recombinant vaccine against porcine circovirus 2.

Fraiberk M, Hájková M, Krulová M, Kojzarová M, Drda Morávková A, Pšikal I, Forstová J.

PLoS One. 2017 Sep 18;12(9):e0184870. doi: 10.1371/journal.pone.0184870. eCollection 2017.

13.

The Identification of Interferon-γ as a Key Supportive Factor for Retinal Differentiation of Murine Mesenchymal Stem Cells.

Hermankova B, Kossl J, Javorkova E, Bohacova P, Hajkova M, Zajicova A, Krulova M, Holan V.

Stem Cells Dev. 2017 Oct 1;26(19):1399-1408. doi: 10.1089/scd.2017.0111. Epub 2017 Aug 22.

PMID:
28728472
14.

Mesenchymal Stem Cells Attenuate the Adverse Effects of Immunosuppressive Drugs on Distinct T Cell Subopulations.

Hajkova M, Hermankova B, Javorkova E, Bohacova P, Zajicova A, Holan V, Krulova M.

Stem Cell Rev Rep. 2017 Feb;13(1):104-115. doi: 10.1007/s12015-016-9703-3.

PMID:
27866327
15.

Distinct Immunoregulatory Mechanisms in Mesenchymal Stem Cells: Role of the Cytokine Environment.

Holan V, Hermankova B, Bohacova P, Kossl J, Chudickova M, Hajkova M, Krulova M, Zajicova A, Javorkova E.

Stem Cell Rev Rep. 2016 Dec;12(6):654-663.

PMID:
27665290
16.

The Supportive Role of Insulin-Like Growth Factor-I in the Differentiation of Murine Mesenchymal Stem Cells into Corneal-Like Cells.

Trosan P, Javorkova E, Zajicova A, Hajkova M, Hermankova B, Kossl J, Krulova M, Holan V.

Stem Cells Dev. 2016 Jun 1;25(11):874-81. doi: 10.1089/scd.2016.0030. Epub 2016 May 9.

PMID:
27050039
17.

Suppression of IL-10 production by activated B cells via a cell contact-dependent cyclooxygenase-2 pathway upregulated in IFN-γ-treated mesenchymal stem cells.

Hermankova B, Zajicova A, Javorkova E, Chudickova M, Trosan P, Hajkova M, Krulova M, Holan V.

Immunobiology. 2016 Feb;221(2):129-36. doi: 10.1016/j.imbio.2015.09.017. Epub 2015 Sep 12.

PMID:
26416211
18.

A local application of mesenchymal stem cells and cyclosporine A attenuates immune response by a switch in macrophage phenotype.

Hajkova M, Javorkova E, Zajicova A, Trosan P, Holan V, Krulova M.

J Tissue Eng Regen Med. 2017 May;11(5):1456-1465. doi: 10.1002/term.2044. Epub 2015 Jun 29.

PMID:
26118469
19.

A low-molecular-weight dialysable leukocyte extract selectively enhances development of CD4⁺RORγt⁺ T cells and IL-17 production.

Zajícová A, Javorková E, Trošan P, Chudíčková M, Krulová M, Holáň V.

Folia Biol (Praha). 2014;60(6):253-60.

20.

Modulation of the early inflammatory microenvironment in the alkali-burned eye by systemically administered interferon-γ-treated mesenchymal stromal cells.

Javorkova E, Trosan P, Zajicova A, Krulova M, Hajkova M, Holan V.

Stem Cells Dev. 2014 Oct 15;23(20):2490-500. doi: 10.1089/scd.2013.0568. Epub 2014 Jul 1.

21.

Common and small molecules as the ultimate regulatory and effector mediators of antigen-specific transplantation reactions.

Holan V, Krulova M.

World J Transplant. 2013 Dec 24;3(4):54-61. doi: 10.5500/wjt.v3.i4.54.

22.

Distinct cytokines balance the development of regulatory T cells and interleukin-10-producing regulatory B cells.

Holan V, Zajicova A, Javorkova E, Trosan P, Chudickova M, Pavlikova M, Krulova M.

Immunology. 2014 Apr;141(4):577-86. doi: 10.1111/imm.12219.

23.

The key role of insulin-like growth factor I in limbal stem cell differentiation and the corneal wound-healing process.

Trosan P, Svobodova E, Chudickova M, Krulova M, Zajicova A, Holan V.

Stem Cells Dev. 2012 Dec 10;21(18):3341-50. doi: 10.1089/scd.2012.0180. Epub 2012 Sep 11.

24.

Cyclosporine A-loaded and stem cell-seeded electrospun nanofibers for cell-based therapy and local immunosuppression.

Holan V, Chudickova M, Trosan P, Svobodova E, Krulova M, Kubinova S, Sykova E, Sirc J, Michalek J, Juklickova M, Munzarova M, Zajicova A.

J Control Release. 2011 Dec 20;156(3):406-12. doi: 10.1016/j.jconrel.2011.07.022. Epub 2011 Jul 23.

PMID:
21802460
25.

The role of mouse mesenchymal stem cells in differentiation of naive T-cells into anti-inflammatory regulatory T-cell or proinflammatory helper T-cell 17 population.

Svobodova E, Krulova M, Zajicova A, Pokorna K, Prochazkova J, Trosan P, Holan V.

Stem Cells Dev. 2012 Apr 10;21(6):901-10. doi: 10.1089/scd.2011.0157. Epub 2011 Jul 26.

26.

Graft survival and cytokine production profile after limbal transplantation in the experimental mouse model.

Lenčová A, Pokorná K, Zajícová A, Krulová M, Filipec M, Holáň V.

Transpl Immunol. 2011 Apr 15;24(3):189-94. doi: 10.1016/j.trim.2010.11.005. Epub 2010 Nov 28.

PMID:
21118723
27.

Treatment of ocular surface injuries by limbal and mesenchymal stem cells growing on nanofiber scaffolds.

Zajicova A, Pokorna K, Lencova A, Krulova M, Svobodova E, Kubinova S, Sykova E, Pradny M, Michalek J, Svobodova J, Munzarova M, Holan V.

Cell Transplant. 2010;19(10):1281-90. doi: 10.3727/096368910X509040. Epub 2010 Jun 23.

PMID:
20573307
28.

Immunoregulatory properties of mouse limbal stem cells.

Holan V, Pokorna K, Prochazkova J, Krulova M, Zajicova A.

J Immunol. 2010 Feb 15;184(4):2124-9. doi: 10.4049/jimmunol.0903049. Epub 2010 Jan 11.

29.

Distinct regulatory roles of transforming growth factor-beta and interleukin-4 in the development and maintenance of natural and induced CD4+ CD25+ Foxp3+ regulatory T cells.

Prochazkova J, Fric J, Pokorna K, Neuwirth A, Krulova M, Zajicova A, Holan V.

Immunology. 2009 Sep;128(1 Suppl):e670-8. doi: 10.1111/j.1365-2567.2009.03060.x. Epub 2009 Jan 24.

30.

Loci controlling lymphocyte production of interferon c after alloantigen stimulation in vitro and their co-localization with genes controlling lymphocyte infiltration of tumors and tumor susceptibility.

Lipoldová M, Havelková H, Badalova J, Vojtísková J, Quan L, Krulova M, Sohrabi Y, Stassen AP, Demant P.

Cancer Immunol Immunother. 2010 Feb;59(2):203-13. doi: 10.1007/s00262-009-0739-y.

31.

A rapid separation of two distinct populations of mouse corneal epithelial cells with limbal stem cell characteristics by centrifugation on percoll gradient.

Krulova M, Pokorna K, Lencova A, Fric J, Zajicova A, Filipec M, Forrester JV, Holan V.

Invest Ophthalmol Vis Sci. 2008 Sep;49(9):3903-8. doi: 10.1167/iovs.08-1987. Epub 2008 May 9.

PMID:
18469183
32.

Production of nitric oxide during graft rejection is regulated by the Th1/Th2 balance, the arginase activity, and L-arginine metabolism.

Holán V, Pindjáková J, Krulová M, Neuwirth A, Fric J, Zajícová A.

Transplantation. 2006 Jun 27;81(12):1708-15.

PMID:
16794538
33.

Corneal rat-to-mouse xenotransplantation and the effects of anti-CD4 or anti-CD8 treatment on cytokine and nitric oxide production.

Pindjáková J, Vítová A, Krulová M, Zajícová A, Filipec M, Holán V.

Transpl Int. 2005 Jul;18(7):854-62.

34.

Susceptibility of corneal allografts and xenografts to antibody-mediated rejection.

Holán V, Vítová A, Krulová M, Zajícová A, Neuwirth A, Filipec M, Forrester JV.

Immunol Lett. 2005 Sep 15;100(2):211-3. Epub 2005 Apr 26.

PMID:
15869803
35.

The activity of inducible nitric oxide synthase in rejected skin xenografts is selectively inhibited by a factor produced by grafted cells.

Holán V, Pindjáková J, Zajícová A, Krulová M, Zelezná B, Matousek P, Svoboda P.

Xenotransplantation. 2005 May;12(3):227-34.

PMID:
15807773
36.

Prevention of corneal allograft rejection in a mouse model of high risk recipients.

Vítová A, Filipec M, Zajícová A, Krulová M, Holán V.

Br J Ophthalmol. 2004 Oct;88(10):1338-42.

37.

Corneal stromal cells selectively inhibit production of anti-inflammatory cytokines by activated T cells.

Holán V, Vítová A, Pindjáková J, Krulová M, Zajícová A, Filipec M.

Clin Exp Immunol. 2004 May;136(2):200-6.

38.

Augmented production of proinflammatory cytokines and accelerated allotransplantation reactions in heroin-treated mice.

Holán V, Zajícová A, Krulova M, Blahoutová V, Wilczek H.

Clin Exp Immunol. 2003 Apr;132(1):40-5.

39.

Mouse genetic model for clinical and immunological heterogeneity of leishmaniasis.

Lipoldová M, Svobodová M, Havelková H, Krulová M, Badalová J, Nohýnková E, Hart AA, Schlegel D, Volf P, Demant P.

Immunogenetics. 2002 Jun;54(3):174-83. Epub 2002 Apr 16.

PMID:
12073146
40.

Nitric oxide as a regulatory and effector molecule in the immune system.

Holán V, Krulová M, Zajícová A, Pindjáková J.

Mol Immunol. 2002 May;38(12-13):989-95.

PMID:
12009578
41.

Alloantigen-induced, T-cell-dependent production of nitric oxide by macrophages infiltrating skin allografts in mice.

Krulová M, Zajícová A, Fric J, Holán V.

Transpl Int. 2002 Mar;15(2-3):108-16. Epub 2002 Mar 1.

PMID:
11935167
42.

The role of macrophages and nitric oxide in the effector phase of allotransplantation reaction.

Holán V, Krulová M, Pindjaková J, Zajícová A.

Ann Transplant. 2001;6(1):44-6.

PMID:
11803606
43.

Immunosuppressive effects of vermiculine in vitro and in allotransplantation system in vivo.

Zajícová A, Múcková M, Krulová M, Rychnavská Z, Holán V.

Int Immunopharmacol. 2001 Oct;1(11):1939-45.

PMID:
11606025
44.

Susceptibility to Leishmania major infection in mice: multiple loci and heterogeneity of immunopathological phenotypes.

Lipoldová M, Svobodová M, Krulová M, Havelková H, Badalová J, Nohýnková E, Holán V, Hart AA, Volf P, Demant P.

Genes Immun. 2000 Feb;1(3):200-6.

45.

Induction of specific transplantation immunity by oral immunization with allogeneic cells.

Holán V, Zajícová A, Krulová M, Plsková J, Fric J, Filipec M.

Immunology. 2000 Nov;101(3):404-11.

46.

A novel alloreactivity-controlling locus, Alan1, mapped to mouse chromosome 17.

Holán V, Havelková H, Krulová M, Demant P, Lipoldová M.

Immunogenetics. 2000 Jul;51(8-9):755-7. No abstract available.

PMID:
10941849
47.
48.

T-cell proliferative response is controlled by loci Tria4 and Tria5 on mouse chromosomes 7 and 9.

Havelková H, Kosarová M, Krulová M, Demant P, Lipoldová M.

Mamm Genome. 1999 Jul;10(7):670-4.

PMID:
10384038
49.

IL-10 is an effector molecule mediating urocanic acid-induced immunosuppression.

Krulová M, Kuffová L, Zajícová A, Filipec M, Holán V.

Transplant Proc. 1999 Feb-Mar;31(1-2):1218-9. No abstract available.

PMID:
10083544
50.

T-cell proliferative response is controlled by locus Tria3 on mouse chromosome 17.

Havelková H, Kosarová M, Krulová M, Holán V, Demant P, Lipoldová M.

Immunogenetics. 1999 Mar;49(3):235-7. No abstract available.

PMID:
9914338

Supplemental Content

Loading ...
Support Center